Skip to main content
. Author manuscript; available in PMC: 2011 Nov 7.
Published in final edited form as: Chem Biol Drug Des. 2009 Dec 17;75(2):143–151. doi: 10.1111/j.1747-0285.2009.00921.x

Figure 5.

Figure 5

The inhibitors bind to the HIV-1 protease in a similar conformation and interact with the same residues in the protease. Shown are surface representations of HIV-1 protease pseudo-wild type bound to KNI-10265 (blue), KNI-10074 (green), and KNI-10006 (gray) (Panel A). In panel B the structure of the bound compounds have been superimposed to indicate that the bind to the protease in the same extended conformation.